ArticleProbiotics and antimicrobial proteins2026
Ethanol-Tolerant Lactobacillus rhamnosus L7 Ameliorates Alcohol-Induced Liver Injury in Mice by Inhibiting the TLR4/MyD88/NF-κB Inflammatory Signaling Pathway and Restoring Gut Microbiota Homeostasis.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Alcohol-related liver disease (ALD) represents a growing global public health concern, and there is still a lack of safe, effective clinical intervention approaches to date. This study aimed to evaluate the protective effect of ethanol-tolerant Lactobacillus (L.) rhamnosus L7 on ALD in mice. In this work, L. rhamnosus L7 with high ethanol tolerance was isolated from fermented grains and pit mud. The strain was intragastrically gavaged to mice with alcoholic liver injury established via the Gao-binge model using the Lieber-DeCarli ethanol liquid diet. Physiological symptoms, histopathological changes, oxidative stress indicators, inflammatory cytokines, gut microbiota composition and the expression of liver injury-related proteins were detected to evaluate the alleviative effect and potential mechanism of L. rhamnosus L7 on alcohol-induced liver injury. The results showed that supplementation with L. rhamnosus L7 significantly decreased serum alanine transaminase (ALT), aspartate transaminase (AST), total cholesterol (TC) and triglyceride (TG) levels. L. rhamnosus L7 intervention markedly alleviated alcohol-triggered hepatic injury, inhibited hepatic steatosis, and alleviated the degree of hepatocellular swelling. Moreover, L. rhamnosus L7 increased the levels of hepatic superoxide dismutase (SOD), catalase (CAT) and total antioxidant capacity (T-AOC), while suppressing the levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), thereby enhancing antioxidant defense and anti-inflammatory capacity. In addition, L. rhamnosus L7 effectively restored gut microbial homeostasis by regulating the structure of gut microbiota at both phylum and species levels. In conclusion, these findings indicate that L. rhamnosus L7 is expected to be developed as a functional probiotic preparation, providing a novel candidate strain and theoretical basis for the alleviation of ALD.
Indexed as
Identifiers
42250157What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.